市場調査レポート
商品コード
1395957
植込み型ポート市場:規模、セグメント別、シェア、法規制、償還、手技、2033年までの予測Implantable Ports Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
植込み型ポート市場:規模、セグメント別、シェア、法規制、償還、手技、2033年までの予測 |
出版日: 2023年11月16日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
|
植込み型ポートは化学療法を必要とする患者に使用されます。中心静脈カテーテルの代わりとして使用されます。また、静脈への薬剤注入や採血にも使用されます。留置ポート、皮下ポートとも呼ばれます。治療のたびに、カテーテルが詰まらないように、少量の液体をカテーテル内に流します。ポートを定期的に使用していない場合は、4~6週間ごとに洗浄する必要があります。
当レポートは、世界の植込み型ポート市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。
Implantable Ports Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Drug Delivery Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Implantable Ports market for the year 2020 and beyond. Implantable ports are used on the patients who require chemotherapy. They are used as a substitute to the central venous catheters. They can be also used for injecting medicine into the vein or to take blood. They are also called as portacaths or subcutaneous ports. After each treatment, a small amount of fluid is flushed into the catheter so it does not get blocked. The port will need to be flushed every 4 to 6 weeks if it is not being used regularly.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are:
Currently marketed Implantable Ports and evolving competitive landscape:
Global, Regional and Country level market specific insights:
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Becton Dickinson and Co, AngioDynamics Inc, B. Braun Melsungen AG, Teleflex Inc, Vygon SA, A.M.I. GmbH, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:
The model will enable you to: